Laylay, Wenejane C.
HRN: 22-02-57 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/27/2023
CEFUROXIME 500MG (TAB)
01/27/2023
02/02/2023
ORAL
500mg
BID
Thickly MSAF
Waiting Final Action